Table 4.
Tissue type | PRP formulation | PRP combination |
Blood volume (mL) | Centrifugation (number of spins) |
PRP volume (mL) |
Platelet concentration | Activator (+/−) |
Leukocytes (+/−) |
PAW classification | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Mice dorsum | PRP | 5–10–15% PRP + ADSCs-microspheres | 30 mL | 2 | NS | NS | 500 U bovine thrombin in 1 mL 10% CaCl2 | NS | x | [12] |
Rat limb | PRP | L-M-H PRP + BMSCs | 40 mL | 2 | NS | High: 4358 ± 265 × 103
Medium: 1453 ± 88 × 103 Low: 48 ± 29 × 103 (platelets/μL) |
CaCl2/thrombin | NS | P4-x P4-x P1-x |
[13] |
Sheep sternum |
PRGF | PRGF | 40 mL | 1 | NS | NS | CaCl2 | NS | x | [30] |
Rat tibia |
PRP | PRP | 20 mL | 2 | 10–15% of total | 1 × 106/μL | CaCl2 | NS | P3-x | [31] |
Rat calvaria |
PRP | PRP | 3.15 mL | 2 | 0.35 mL | 1852.307 ± 1084.85 × 103/µL | CaCl2 | NS | P4-x | [32] |
Rat calvaria |
PRP | PRP | 3.15 mL | 2 | 0.35 mL | 2977.66 ± 1174.83 × 103/ µL |
10% CaCl2
25% thromboplastin |
NS | P4-x | [33] |
Rat femur |
PRP | PRP | NS | 2 | NS | NS | CaCl2/ thrombin |
NS | x | [34] |
Mouse calvaria |
PRF | PRF | NS | NS | NS | NS | NS | NS | Not applicable | [35] |
Rabbit calvaria |
PRP | PRP | 10 mL | 1 | ~0.9 mL | NS | CaCl2 | NS | x | [36] |
Rabbit calvaria |
PRP PPP |
PRP PPP |
130 mL | 2 | NS | 900,000/µL | Thrombin/ CaCl2 |
NS | P3-x | [37] |
Ovx. rat femur |
PRP | -H-PRP; -M-PRP; -L-PRP; -PPP |
NS | 3 | NS | H-PRP: 8.21 ± 0.4 × 109/mL; M-PRP: 2.65 ± 0.2 × 109/mL; L-PRP: 0.85 ± 0.16 × 109/mL; PPP: 8 ± 0.5 × 106/mL | Thrombin/ CaCl2 |
NS | P4-x P4-x P3-x P3-x |
[38] |
Ovx. mice femur |
PRP | PRP | NS | NS | NS | NS | NS | NS | Not applicable | [39] |
Mini. pig tibia |
PRP | PRP + AB | 120 mL | 1 | 20 mL | NS | Thrombin/ CaCl2 |
NS | x | [40] |
Rabbit tibia |
PRP | PRP + AB | 10 mL | 2 | NS | NS | CaCl2/ thrombin |
NS | x | [41] |
Rabbit tibia |
PRP | PRP + AB | 10 mL | 1 | 0.5 mL | NS | CaCl2 | NS | x | [42] |
Rat calvaria |
PRP | PRP 50–100–150 µL + AB | 3.15 mL | 2 | 0.35 mL | 2611.80 ± 313.34 × 103/µL |
CaCl2 | NS | P4-x | [43] |
Rabbit calvaria |
PRP | PRP + AB | 40 mL | 1 | NS | NS | CaCl2 | NS | x | [44] |
Rat calvaria |
PRP | PRP 50–100–150 µL + AB | 3.15 mL | 2 | 0.35 mL | 2,718.46 ± 359.65 × 103 platelets/µL. | CaCl2 | NS | P4-x | [45] |
Rabbit femur |
PRP | PRP + Bioss Collagen | 4 mL | NS | NS | NS | NS | NS | Not applicable | [46] |
Dog tibia | PRP | PRP + Bio-Oss | 20 mL | 2 | NS | 1.380.000 | CaCl2/ thrombin |
NS | Not applicable | [47] |
Rat calvaria |
PRP | PRP + FFBA | 3.15 mL | 2 | 0.35 mL | 2,628.8 ± 603.07 × 103/µL | CaCl2 | NS | P4-x | [48] |
Rabbit calvaria |
PRP | PRP + particulated AB | 38 mL | 1 | 5 mL | 1,7 × 106 ± 680,200/µL | Thrombin/ CaCl2 |
13.42 × 109/L | P4-x | [49] |
Rabbit calvaria |
PRP | PRP + AB | 15 mL | 2 | 1 mL | 2,4 × 106 ± 1,5 × 106/μL |
CaCl2 | NS | P4-x | [50] |
Rabbit calvaria |
PRP | PRP + AB | 15 mL | 2 | 1 mL | 2.564 × 106 ± 1.621 × 106/μL |
CaCl2 | NS | P4-x | [51] |
Rabbit calvaria |
PRP | PRP* + AB PRP° + AB |
10 mL | 1*
2° |
1 mL*
0.5 mL° |
NS | CaCl2 | NS | x | [52] |
Rabbit calvaria |
PRP | hPRP + AB | 10 mL | 2 | 1 mL | 2.414.720 ± 1547.862 platelets/mL | CaCl2/ thrombin |
NS | P1-x | [53] |
Rabbit calvaria |
PRP | PRP + AB + receptor bed | 10 mL | 2 | NS | 1,2 × 106 platelets/mm3 | Thrombin/ CaCl2 |
NS | P3-x | [54] |
Goat's frontal bone |
PRP | PRP + AB | 250 mL | NS | NS | 800 × 109/L | CaCl2/ bovine thrombin |
NS | P3-x | [55] |
Goat's frontal bone |
PRP | PRP + AB + BioOss | 250 cm3 | 4 | NS | 800–1000 × 109/L | CaCl2/ bovine thrombin |
NS | P3-x | [56] |
Rabbit femur |
PRGF | PRGF + DBBM | 10 mL | 1 | 1 mL | NS | CaCl2 | NS | x | [57] |
Rabbit radius |
PRP | hPRP + HA | 500 mL | 1 | NS | 2,422 × 109L | NS | NS | P4 | [58] |
Mini. pig's subcutis |
PRP | PRP + Bovine HA or Phycogenic HA or Bioglass | 250 mL | NS | NS | 483.8 ± 97.2 × 103/µL | NS | 24.8 ± 8.9 × 103/µL | P2-A | [59] |
Rabbit condyle |
PRP | PRP + CPC | NS | NS | NS | NS | NS | NS | Not applicable | [60] |
Mini. pig tibia |
PRP | PRP + Ca-P | 120 mL | 2 | 20 mL | NS | Thrombin/ CaCl2 |
NS | x | [61] |
Rat cranium |
PRP | PRP + HA or β-TCP | NS | NS | NS | NS | CaCl2/ thrombin |
NS | x | [62] |
Rabbit radius |
PRP | PRP + BG | 10 mL | 1 | 0.8 mL | NS | CaCl2/ thrombin |
NS | x | [63] |
Rabbit calvaria |
PRP | PRP + rhBMP2-BCP | 10 mL | 2 | NS | 78.1 ± 1.62 × 104/mm3 | CaCl2/ thrombin |
NS | P3-x | [64] |
Rabbit iliac crest |
PRP | PRP + ringed PTFE vascular grafts + HA or collagen gel beads | 5 mL | 2 | 0.18 mL | 1,100 ± 332 × 103/µL | NS | NS | P3 | [65] |
Rabbit radius |
PRP | PRP + Ti + Bone | 10 mL | 2 | 1 mL | 1.0– 1.5 × 1012 thrombocytes/L |
Thrombin/ CaCl2 |
NS | P3-x | [66] |
Nude rat calvaria |
PRP | PRP + PGA + rhBMP-2 | NS | NS | NS | NS | CaCl2/ thrombin |
NS | x | [67] |
Rat femur |
PRP | PRP + PCL-TCP | 10 mL | 2 | 1.5 mL | ~600 × 103platelets/mL | CaCl2/ thrombin |
NS | P2-x | [68] |
Rat ulna |
PRP | PRP + gelatin hydrogel + SEW2871-micelles | 10 mL | 2 | 1 mL | NS | CaCl2 | NS | x | [69] |
Rabbit calvaria |
PRP | Activated/inactivated PRP + gelatine hydrogel | NS | NS | ~0.8 mL | NS | Thrombin/ CaCl2 |
NS | x | [70] |
Cattle hoof |
PRP | PRP + Gelatin microspheres + alginate | NS | 2 | 1 mL | 152.8 ± 98.7 × 104 platelets/μL | CaCl2 | NS | P4-x | [71] |
Rabbit radius |
PRP | hPRP + Persian Gulf Coral | 500 mL | NS | NS | 2422 × 109/L | NS | NS | P4 | [72] |
Rabbit radius |
PRP | hPRP + coral | NS | NS | NS | 2422 × 109/L | NS | NS | P4 | [73] |
Rabbit cranium |
PRP | PRP + chitosan sponge | 8 mL | 2 | 0.6-0.7 mL | NS | CaCl2 | NS | x | [74] |
Rabbit fibula |
PRP | APC + HBO | 2.5 mL | 1 | 1.5 mL | NS | NS | NS | Not applicable | [75] |
Beagles calvaria |
PRP | PRP + PDBM or Lactosorb or BMP | 27 mL | 1 | 3 mL | NS | CaCl2/ thrombin |
NS | x | [76] |
Goats cranium |
PRP | rPRP or hPRP or gPRP + HA or β-TCP; hPRP + bone |
500 mLh
250 cm3 g |
NS | NS | NS | CaCl2/ thrombin |
NS | x | [77] |
Rabbit calvaria |
PRP | PRP + β-TCP | 8 mL | 2 | 0.7 mL | NS | NS | NS | Not applicable | [78] |
Rabbit spinal fusion |
PRP | PRP + Calcium Carbonate + HA | 54 mL | 2 | 10 mL | NS | thrombin/ CaCl2 |
NS | x | [79] |
Ovx. rat calvaria |
PRP | PRP + CA + Mel | 4 mL | NS | 325 µL | NS | NS | NS | Not applicable | [80] |
Porcine skull | PRP | PRP + ankyloss graft | NS | NS | NS | 118 ± 12 thrombocytes 1000/µL |
CaCl2/ thrombin |
4.3 ± 1.9 leukocytes 1000/µL |
P1-x-B | [81] |
Goats tibia | PRP | PRP liquid or PRP gel + non-coated or Ca-P-coated implant | 250 mL | NS | 7.5 mL | 800–1200 × 106/mL | CaCl2/ bovine thrombin |
NS | P3-x | [82] |
Rabbit calvaria |
PRP | PRP + BMSCs | 10 mL | 2 | 1 mL | NS | NS | NS | Not applicable | [83] |
Rabbit calvaria |
PRP | PRP + induced/uninduced BMSCs | 7 mL | 2 | NS | NS | CaCl2/ thrombin |
NS | x | [84] |
Mice calvaria |
PRP | PRP + BMSCs | 2.0 mL | 2 | NS | NS | 10% calcium gluconate | NS | x | [85] |
Sheep tibia |
PRP | hPRP + ADSCs | 2 | NS | 1.0 × 109/mL | CaCl2/ thrombin |
NS | P3-x | [86] | |
Nude mice inguinal groove |
PRP | hPRP + hADSCs | 400 mL | 3 | NS | NS | Thrombin/ CaCl2 |
NS | x | [87] |
Rat calvaria | PRP | PRP + BCP or MSCs | NS | 2 | 0.5 mL | NS | NS | NS | Not applicable | [88] |
Rabbit radius |
PRP | PRP + CDHA + BMSC | NS | NS | NS | NS | CaCl2/ thrombin |
NS | x | [89] |
Rabbit radius |
PRP | PRP + CDHA + MSC | NS | NS | NS | NS | Thrombin/ CaCl2 |
NS | x | [90] |
Rabbit ulna |
PRP Gel Membrane | PRP + rBMSCs + nanohydroxypaptite poly (ester urethane) | NS | 3 | NS | 3 × 106 platelets/µL | NS | NS | P4 | [91] |
Rabbit tibia | PRP | PRP + β-TCP + BMC | 9 mL | 1 | NS | NS | Calcium gluconate | NS | x | [92] |
Nude mice cranium | PRP | PRP + β-TCP + BMAC |
27 mL | NS | NS | NS | NS | NS | Not applicable | [93] |
Rabbit calvaria |
PRPGF | PRGF + Nano-HA granule + MSCs | 10 mL | 1 | 1 mL | NS | CaCl2 | NS | x | [94] |
Rabbit radius |
PRP | PRP + DPB + MSCs | 60 mL | 2 | NS | 12.87 ± 0.848 × 106/μL |
CaCl2/ thrombin |
NS | P4-x | [95] |
Rat calvaria |
PRP | PRP + BiOss + BMSCs | 3 mL | 2 | 0.5 mL | NS | NS | NS | Not applicable | [18] |
Rabbit patellar tendon | PRP | PRP | 8 mL | 1 | 2 mL | NS | NS | NS | Not applicable | [96] |
Rabbit patellar tendon | PRP | PRP | 8 mL | 1 | 2 mL | NS | NS | NS | Not applicable | [97] |
Rabbit Achilles tendon | PRP | PRP | 8 mL | 1 | 2 mL | NS | NS | NS | Not applicable | [98] |
Horse SDFT | PRP | PRP | NS | NS | 3 mL | NS | NS | NS | Not applicable | [99] |
Horse SDFT | PRP | PRP | NS | NS | 3 mL | 639.7 ± 103.2 × 109/L | NS | 42.1 ± 16.7 × 109/L | P2-A | [100] |
Rat patellar tendons | PRP | PRP | 60 mL | 2 | NS | 523.8 × 104/mL | NS | NS | P1 | [101] |
Rat rotator cuff |
PRP | PRP | 5 mL | 2 | NS | 13.8 × 109 platelets/L | NS | NS | P1 | [102] |
Rat Achilles tendon | PRP | PRP | NS | 2 | NS | (2.2–2.9) × 106/mm3 | CaCl2 | 1 × 102/mm3 | P4-x-B | [103] |
Rat tendon-from-bone supraspinatus tear |
PRP | PRP | 7-8 mL | 2 | NS | NS | CaCl2/thrombin | NS | x | [104] |
Rabbit Achilles tendon |
PRP | PRP | 8 mL | NS | 2 mL | NS | NS | NS | Not applicable | [105] |
Sheep Achilles tendon | PRGF | PRGF | 20 mL | 1 | 2 mL | NS | CaCl2 | NS | x | [106] |
Rabbit intrasynovial flexor tendons |
PRPF | PRP/PRPF | 10 mL | 2 | ns | 313.5 (±72.3) × 104 μL | CaCl2/thrombin | NS | P4-x | [107] |
Rat patellar tendon | PC | PC | 9 mL | 1 | 0.5 mL | 445–862 thousand/mm3 | NS | NS | P2/P3-x | [108] |
Sheep DDFT |
PRP | PRP + 10 × 106 autologous PB-MSCs | 18 mL | NS | 3/5 mL | 882 ± 199 × 103 platelet/μL | NS | NS | P3 | [109] |
Rabbit Achilles tendon |
PRP | PRP + 1 × 107 ADSCs | 10 mL | 2 | NS | NS | CaCl2 | NS | x | [110] |
Sheep Achilles tendon | PRPFM | PRPFM + APD | 9 mL | NS | NS | NS | NS | NS | Not applicable | [111] |
Rat Achilles tendon | PRP | PRP + Collagen sponge + TSCs | 20 mL | 2 | NS | 8 × 109 platelets/L | NS | NS | P1 | [112] |
Mice abdominal cavities | PRCR | 10% PRCR in DCs | 50 mL | 2 | NS | 10.0 × 108 platelets/mL | CaCl2 | NS | P3-x | [113] |
Rabbit articular cartilage | PRP | PRP + PLGA | 16 mL | 2 | 0.8 mL | 125.59 × 104/μL | NS | NS | P4 | [114] |
Sheep articular cartilage | PRP | PRP + collagen-HA | 20 mL | 1 | NS | 874 ± 87 × 103/μL | CaCl2 | NS | P3-x | [115] |
Caprine articular cartilage | PRP | PRP + DBM | 27 mL | 1 | 3 mL | 1511 × 109/L | NS | NS | P4 | [116] |
Rabbit articular cartilage | PRP | PRP + chondrocytes | 10 mL | 2 | 1 mL | NS | NS | NS | Not applicable | [117] |
Rabbit articular cartilage | PRP | PRP + BMSCs PRP + ADSCs |
18 mL | 2 | 0.5 mL | 16.7 ± 1.1 × 108/mL | Ca | NS | P4-x | [118] |
Rabbit articular cartilage | PRP | PRP + SDMC | 9 mL | 2 | 1 mL | 2103.56 ± 479.5 × 103/mL | NS | NS | P4 | [119] |
Rat articular cartilage | PRP | PRP + hydrogel + chondrocytes | 40 mL | 2 | NS | 1240.9 ± 86.1 × 104/µL | NS | NS | P4 | [120] |
Rabbit articular cartilage | PRP | PRP + hydrogel + chondrocytes | 10 mL | 2 | NS | NS | NS | NS | Not applicable | [121] |
Mini pig articular cartilage | PRP | PRP + BMSCs + biphasic scaffold | 60 mL | 1 | 10 mL | 2.2 ± 0.57 × 106 cells | Thrombin/CaCl2 | NS | Not applicable | [122] |
Rabbit articular cartilage | PRP | Autologous cartilage fragments + hyaluronic acid derivative + human fibrin glue + PRP | 8 mL | 2 | 400 µL | 858 × 103 platelets/mm3 (range 642–1,085) | NS | NS | P3 | [123] |
Sheep cartilage | PRP | PRP + microfractures | 60 mL | 2 | 6–8 mL | 1415 ± 164 × 103/mL | Fibrinogen Thrombin |
NS | P1-x | [124] |
Rat articular cartilage | PRP | PRP + microfractures | NS | 2 | NS | 13.8 × 109 platelets/L | NS | NS | P1 | [125] |
Porcine ACL | PRP | Collagen-PRP hydrogel | 60 mL | 2 | 9 mL | NS | NS | NS | Not applicable | [126] |
Canine ACL | PRP | Collagen-PRP hydrogel | NS | 1 | NS | NS | NS | NS | Not applicable | [127] |
Canine ACL | PRP | Collagen-PRP hydrogel | NS | NS | NS | NS | NS | + | Not applicable | [128] |
Mini. pig ACL | PRP | 3X or 5X PRP + collagen scaffold | NS | NS | NS | 1951 ± 304 × 109/L 1161 ± 179 × 109/L |
NS | NS | P4 P3 |
[129] |
Rabbit ACL |
PRP | PRP + DPB | NS | 2 | NS | NS | CaCl2/bovine thrombin | NS | x | [130] |
Canine ACL | PRP | PRP | 20 mL | 3 | 1 mL | 669 ± 51 × 109 platelets/L | NS | NS | P2 | [131] |
Not specified (NS), biphasic calcium phosphate (BCP), mesenchymal stem cell (MSC), beta-tricalcium phosphate (β-TCP), polytetrafluoroethylene (PTFE), platelet-rich growth factor (PRGF), autologous bone (AB), hydroxyapatite (HA), calcium phosphate cement (CPC), bone marrow mesenchymal stem cells (BMSCs), calcium aluminate (CA), rabbit BMSC (rBMSC), deproteinized bovine bone mineral (DBBM), calcium-deficient hydroxyapatite (CDHA), allogeneic-mesenchymal stem cells (aMSC), titanium (Ti), human adipose derived stem cell (hADSC), human PRP (hPRP), fresh frozen bone allograft (FFBA), autogenous bone (AB), hyperbaric oxygen (HBO) therapy, autologous platelet concentrate (APC), adipose tissue derived stem cells (ASC), calcium phosphate (Ca-P), autogenous particled bone (APB), allogeneic BMSC (aBMSCs), acellular porcine dermal patch (APD) polyglycolic acid (PGA), recombinant human bone morphogenetic proteins (rhBMP2), platelet-poor plasma (PPP), rat PRP (rPRP), human PRP (hPRP), goat (gPRP), perforated bone matrix (PDBM), bone morphogenetic proteins (BMP), polycaprolactone-20% tricalcium phosphate (PCL-TCP), (5-[4-phenyl-5-(trifluoromethyl) thiophen-2-yl]-3-[3-(trifluoromethyl) phenyl] 1,2,4-oxadiazole) SEW2871, borate glass (BG), platelet-rich fibrin (PRF), deproteinized bone matrix (DPB), low-medium-high PRP (L-M-H PRP), bone marrow cells (BMC), adipose derived stem cell (ADSC) bone marrow aspirate concentrate (BMAC), superficial digital flexor tendon (SDFT), deep digital flexor tendon (DDFT), anterior cruciate ligament (ACL), platelet-rich plasma fibrin matrix (PRPFM), concentrate plasma (PC), platelet-rich plasma-clot release (PRCR), plasma rich in growth factors (PRGF), PRP with fibrin matrix (PRPF), tendon stem cells (TSCs), periferal blood mesenchymal stem cells (PB-MSCs), adipose derived mesenchymal stem cells (ADSCs), white blood cells (WBC), poly(lactic-co-glycolic acid) (PLGA), demineralized bone matrix (DBM), hydroxyapatite (HA), synovial membrane derived mesenchymal stem cell (SDMC), bone marrow mesenchymal stem cell (BMSC), adipose derived stem cell (ADSC), deproteinized bone (DPB), and calcium chloride (CaCl2), calcium (Ca).
*Anitua method. °Sonnleitner method.
PAW classification: P1 (≤baseline), P2 (>baseline-750,000), P3 (>750,000–1,250,000), P4 (>1,250,000), x (exogenous activation), A (above baseline), B (below baseline), h (human), and g (goat).